David Emerson Jorden insider trades: Nuo Therapeutics (AURX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where David reports to the SEC





and 4 more companies
Open-market buys and sales
110 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 28, 2026 | AURX | ↑ Buy | 8,773 | $1.09 | $10K | Direct | Aug 31, 2026 (3d) |
| Nov 28, 2025 | AURX | ↓ Sell | 200,000 | $1.50 | $300K | Direct | Dec 3, 2025 (5d) |
| Nov 9, 2022 | AURX | ↓ Sell | 162,500 | $1.50 | $244K | Direct | Nov 14, 2022 (5d) |
| Aug 10, 2017 | AURX | ↑ Buy | 247,500 | $0.22 | $55K | Direct | Aug 14, 2017 (4d) |
| Jun 14, 2017 | PLXP | ↑ Buy | 32,727 | $6.88 | $225K | Direct | Jun 16, 2017 (2d) |
| May 5, 2016 | NONE | ↑ Buy | 137,500 | $1.00 | $138K | Direct | Jul 29, 2016 (85d) |
| May 21, 2013 | CMXI | ↑ Buy | 80,000 | $0.50 | $40K | Direct | May 21, 2013 (0d) |
| Apr 19, 2013 | CMXI | ↑ Buy | 50,000 | $0.51 | $25K | Direct | Apr 19, 2013 (0d) |
| Apr 9, 2013 | CMXI | ↑ Buy | 75,000 | $0.51 | $39K | Direct | Apr 9, 2013 (0d) |
| Feb 27, 2013 | CMXI | ↑ Buy | 25,000 | $0.52 | $13K | Direct | Feb 27, 2013 (0d) |
| Feb 22, 2013 | CMXI | ↑ Buy | 50,000 | $0.53 | $27K | Direct | Feb 22, 2013 (0d) |
| Sep 14, 2012 | CMXI | ↑ Buy | 25,000 | $0.89 | $22K | Direct | Sep 14, 2012 (0d) |
| Sep 11, 2012 | CMXI | ↑ Buy | 8,333 | $0.95 | $8K | Direct | Sep 12, 2012 (1d) |
| Feb 15, 2012 | CMXI | ↓ Sell | 143,088 | $1.19 | $170K | Direct | Feb 15, 2012 (0d) |
| Jun 7, 2011 | CMXI | ↑ Buy | 22,500 | $0.34 | $8K | Direct | Jun 7, 2011 (0d) |
| May 20, 2011 | CMXI | ↑ Buy | 15,000 | $0.38 | $6K | Direct | May 20, 2011 (0d) |
| May 19, 2011 | CMXI | ↑ Buy | 22,500 | $0.39 | $9K | Direct | May 20, 2011 (1d) |
| May 4, 2011 | CMXI | ↑ Buy | 17,500 | $0.36 | $6K | Direct | May 4, 2011 (0d) |
| May 3, 2011 | CMXI | ↑ Buy | 18,000 | $0.34 | $6K | Direct | May 3, 2011 (0d) |
| May 2, 2011 | CMXI | ↑ Buy | 252,000 | $0.33 | $84K | Direct | May 3, 2011 (1d) |
| Mar 16, 2011 | CMXI | ↑ Buy | 27,500 | $0.38 | $10K | Direct | Mar 16, 2011 (0d) |
| Mar 15, 2011 | CMXI | ↑ Buy | 12,500 | $0.40 | $5K | Direct | Mar 15, 2011 (0d) |
| Mar 14, 2011 | CMXI | ↑ Buy | 35,000 | $0.39 | $14K | Direct | Mar 15, 2011 (1d) |
| Mar 11, 2011 | CMXI | ↑ Buy | 35,000 | $0.40 | $14K | Direct | Mar 14, 2011 (3d) |
| Mar 9, 2011 | CMXI | ↑ Buy | 72,200 | $0.40 | $29K | Direct | Mar 10, 2011 (1d) |
| Mar 9, 2011 | CMXI | ↑ Buy | 72,200 | $0.40 | $29K | Direct | Mar 9, 2011 (0d) |
| Mar 8, 2011 | CMXI | ↑ Buy | 72,800 | $0.41 | $29K | Direct | Mar 8, 2011 (0d) |
| Feb 17, 2011 | CMXI | ↑ Buy | 13,414 | $0.43 | $6K | Direct | Feb 22, 2011 (5d) |
| Feb 17, 2011 | CMXI | ↑ Buy | 41,586 | $0.44 | $18K | Direct | Feb 18, 2011 (1d) |
| Feb 15, 2011 | CMXI | ↑ Buy | 15,000 | $0.42 | $6K | Direct | Feb 15, 2011 (0d) |
| Feb 14, 2011 | CMXI | ↑ Buy | 12,450 | $0.44 | $5K | Direct | Feb 15, 2011 (1d) |
| Feb 11, 2011 | CMXI | ↑ Buy | 27,550 | $0.44 | $12K | Direct | Feb 14, 2011 (3d) |
| Feb 9, 2011 | CMXI | ↑ Buy | 10,000 | $0.45 | $5K | Direct | Feb 9, 2011 (0d) |
| Feb 4, 2011 | CMXI | ↑ Buy | 15,000 | $0.45 | $7K | Direct | Feb 4, 2011 (0d) |
| Jan 25, 2011 | GTF | ↑ Buy | 17,000 | $0.48 | $8K | Direct | Jan 25, 2011 (0d) |
| Jan 24, 2011 | GTF | ↑ Buy | 52,000 | $0.47 | $24K | Direct | Jan 24, 2011 (0d) |
| Dec 27, 2010 | GTF | ↑ Buy | 12,500 | $0.47 | $6K | Direct | Dec 28, 2010 (1d) |
| Dec 22, 2010 | GTF | ↑ Buy | 12,500 | $0.46 | $6K | Direct | Dec 22, 2010 (0d) |
| Dec 21, 2010 | GTF | ↑ Buy | 22,000 | $0.45 | $10K | Direct | Dec 22, 2010 (1d) |
| Dec 17, 2010 | GTF | ↑ Buy | 32,000 | $0.46 | $15K | Direct | Dec 21, 2010 (4d) |
| Dec 17, 2010 | GTF | ↑ Buy | 27,500 | $0.47 | $13K | Direct | Dec 17, 2010 (0d) |
| Dec 16, 2010 | GTF | ↑ Buy | 14,000 | $0.49 | $7K | Direct | Dec 17, 2010 (1d) |
| Dec 15, 2010 | GTF | ↑ Buy | 15,000 | $0.48 | $7K | Direct | Dec 15, 2010 (0d) |
| Dec 14, 2010 | GTF | ↑ Buy | 15,500 | $0.47 | $7K | Direct | Dec 14, 2010 (0d) |
| Dec 10, 2010 | GTF | ↑ Buy | 16,200 | $0.48 | $8K | Direct | Dec 10, 2010 (0d) |
| Dec 8, 2010 | GTF | ↑ Buy | 22,183 | $0.47 | $10K | Direct | Dec 8, 2010 (0d) |
| Dec 7, 2010 | GTF | ↑ Buy | 26,300 | $0.48 | $13K | Direct | Dec 7, 2010 (0d) |
| Dec 6, 2010 | GTF | ↑ Buy | 22,730 | $0.46 | $10K | Direct | Dec 7, 2010 (1d) |
| Dec 3, 2010 | GTF | ↑ Buy | 75,257 | $0.46 | $35K | Direct | Dec 6, 2010 (3d) |
| Dec 2, 2010 | GTF | ↑ Buy | 37,792 | $0.46 | $17K | Direct | Dec 3, 2010 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About David Emerson Jorden's insider trades
David Emerson Jorden is CEO/CFO at Nuo Therapeutics (AURX). Since Sep 30, 2008, David has reported 107 open-market purchases worth $2.2M and 3 sales worth $714K on SEC Form 4. In the last 12 months: 1 buy ($10K) and 1 sale ($300K).
Their filings also include grants and awards (27 filings), other transactions (22 filings), option exercises (5 filings), conversions (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AURX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.